대암

비상장계속사업자

DAE AM

조성혁

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

대암

Business Reg. No. 3188108028 · CEO 조성혁

I.Investment Overview

Target대암 (3188108028)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명대암
영문명DAE AM
대표자조성혁
사업자등록번호3188108028
법인등록번호1701110565393
설립일2015.09.10

V.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW31.1202134.1202234.8202334.9202435.32025
영업이익100M KRW18.1202120.7202220202318.2202418.52025
순이익100M KRW7.220212.92022-0.42023-120243.62025
Item20252024202320222021
자산총계519.3억원514.4억원515.1억원522.9억원526.3억원
부채총계469.8억원468.5억원468.2억원475.6억원482억원
자본총계49.5억원45.9억원46.9억원47.2억원44.3억원
매출액35.3억원34.9억원34.8억원34.1억원31.1억원
영업이익18.5억원18.2억원20억원20.7억원18.1억원
순이익3.6억원-9,758만원-3,505만원2.9억원7.2억원

VI.Financial Ratios

FY2025 basis

52.42%

영업이익률

10.15%

순이익률

0.69%

ROA

7.23%

ROE

949.16%

부채비율

9.53%

자기자본비율

VII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

대암 투심보고서 | Alpha Lenz